Generate:Biomedicines

In her latest article for Second Opinion Media, Christina Farr identifies five healthcare sectors where #AI is driving transformation—including drug discovery. Generate:Biomedicines is featured as a “native Gen AI-driven TechBio company” advancing a pipeline through clinical development. The article underscores what sets us apart: not just building tools, but generating and advancing wholly novel therapeutics—designed from first principles—using our own data, models, and platform. It’s a timely snapshot of how generative approaches are moving from theory to practice—and why foundational innovation in biology will define the next era of medicine. Read more here: https://lnkd.in/gR_Z2hPi #ProgrammingBiology | #NowWeCan

Today, we celebrate the birthday of Rosalind Franklin – the pioneering British chemist whose groundbreaking X-ray crystallography work at King’s College was instrumental in the discovery of DNA’s double-helix structure. Her contributions laid the foundation for structural biology as we know it. At Generate:Biomedicines, understanding molecular structures is in our DNA. Our Andover facility, which opened in 2023, is home to four #CryoEM microscopes that use #AI-powered automated lab workflows to solve complex molecular structures at scale. By feeding the terabytes of structural data produced by our CryoEM lab into our platform, we're accelerating the design of novel protein therapeutics with unprecedented speed, precision, and intent. We're proud to continue Rosalind Franklin’s legacy of scientific innovation. Join us in pushing the boundaries of what’s possible: https://lnkd.in/gKaKkEGJ #WomeninScience | #RosalindFranklin 

We’re fundamentally changing the way medicines are made. Come watch it happen. Our YouTube channel is your inside look into the world of programmable biology with interviews, announcements, scientific deep dives, and more. See how #TeamGenerate is using #GenerativeAI to design—not discover—novel protein-based therapeutics with the precision and rigor required to function in complex biological systems. Translation—not novelty—is the real test. Follow our scientific journey as we redefine what’s possible: https://lnkd.in/e6h4rcXd #ProgrammingBiology | #NowWeCan

What will determine which AI biotechs lead the next era of drug development? In her article for Scrip (Citeline), Mandy Jackson argues it won’t be model sophistication alone—but whether those models are used to solve the right problems. She points to Generate:Biomedicines as a standout: a company pairing cutting-edge generative models with in-house experimental and clinical execution. Jackson highlights GB-0895, our anti-TSLP candidate for severe asthma, progressing toward late-stage trials, as one example of that strategy in action. Our CEO Michael Nally emphasizes that success depends not just on design, but on execution. In a market demanding proof, we are delivering: #AI-built, human-tested, and clinically validated. Not theory—translation at scale. Read more: https://lnkd.in/ettqVBh7 #ProgrammingBiology | #NowWeCan

During our summer shutdown, members of #TeamGenerate traded their laptop screens and lab coats for two wheels – taking the road less traveled.    From the rugged routes of the Lutsen 99er race in Minnesota’s Sawtooth Mountains to the winding, lavender-lined streets in Provence, France – Generators embraced cycling adventures across the globe.     Whether at the lab bench or out in the world, we show up with the same mindset we bring to pursuing our mission of changing the way medicines are made: focused, intentional, and all-in.    If you this sounds like your kind of team, join us for the ride: https://lnkd.in/gKaKkEGJ    #AudaciouslyAmbitious | #FiercelyUnited 

ICYMI: What happens when #AI isn’t just layered onto biology—but built into it? In this conversation with Pierre FERRAGU of New Street Research, our CEO Michael Nally shares how #TeamGenerate is using generative AI to intentionally design proteins and program biology—moving beyond traditional drug discovery. From cutting-edge generative models to experimental automation, Mike shares how our platform is transforming the economics of therapeutic development, significantly reducing the time and cost of identifying clinical candidates—because novelty alone isn’t enough. It’s about delivering better medicines faster and more precisely. Watch the full conversation on our YouTube channel: https://lnkd.in/e_ugu2Zi #ProgrammingBiology | #NowWeCan

For #TeamGenerate, rest is a system feature—built in with the same intention as any part of our platform. Because sustainable progress takes clarity, and because innovation requires space to think, reset, and return with focus. Next week, we pause for our summer shutdown: a company-wide break to rest, reflect, and recharge. And before we go offline, we came together to celebrate. From our Pride Month traditions to food truck lunches, these moments of connection reinforce what makes #TeamGenerate so distinct. We’re not just building a new approach to drug development—we’re building a culture where every Generator can focus on advancing what’s possible in medicine. Join us: https://lnkd.in/gKaKkEGJ #FiercelyUnited | #PrideInBelonging

In her coverage of the 2025 Biotechnology Innovation Organization (BIO) International Convention, Mandy Jackson of Scrip (Citeline) highlights how regulatory uncertainty and market constraints continue to weigh on biotech dealmaking and investment decisions across the industry. Our CEO, Michael Nally, shared our perspective on managing these dynamics—not only by advancing GB-0895, our anti-TSLP candidate for severe asthma, toward later-stage trials, but also by investing strategically in our underlying technology. For us, balancing immediate pipeline progress with ongoing platform investment remains critical. Read Mandy’s full analysis here: https://lnkd.in/eeHF5aCU #ProgrammingBiology | #BIO2025

Making an impact is in our DNA—whether it's reimagining what medicines can do or supporting the communities we call home. Recently, #TeamGenerate hosted a fundraiser for Horizons for Homeless Children to support early education, play spaces, and family services for children experiencing homelessness. A special thank you to Kaivalya Molugu, PhD, Julia A. Jones, and Ilja Kuesters for spearheading this initiative with creativity, care, and intent. Your dedication exemplifies what it means to be #FiercelyUnited. If this sounds like your kind of team, join us: https://lnkd.in/gKaKkEGJ #NowWeCan | #PurposeInPractice  

#TeamGenerate thrives on diverse thinking—and today, on International Women in Engineering Day, we honor the incredible contributions of the women engineers whose curiosity, creativity, and expertise power our platform. This year’s theme, #TogetherWeEngineer, reminds us that solving complex biological challenges requires bringing many voices into the room. From molecular design to automation systems to data science, our female engineers are shaping a more inclusive and innovative future for #GenerativeBiology. Today and every day, we stand together. If you’re an engineer who believes in impact through biology, join our mission: https://lnkd.in/gKaKkEGJ #INWED25 | #TogetherWeEngineer